Analyst Research Roundup: Coupa Software Incorporated (COUP), Exact Sciences Corporation (EXAS)

Coupa Software Incorporated (NASDAQ:COUP) tinted loss of -2.77% (-2.59 points) to US$91.05. The volume of 1.56 Million shares climbed up over an trading activity of 1.31 Million shares. EPS ratio determined by looking at last 12 month figures is -0.85. Over the same time span, the stock marked US$99.64 as its best level and the lowest price reached was US$43.89. The corporation has a market cap of US$5.5 Billion.

Coupa Software Incorporated (NASDAQ:COUP)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at -18.1 percent while most common profitability ratio return on investment (ROI) was -11.6 percent. The company’s institutional ownership is monitored at 0 percent. The company’s net profit margin has achieved the current level of -19.9 percent and possesses 68.7 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 7 think it is Hold. Recently, analysts have updated the overall rating to 2.33. 6 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

Exact Sciences Corporation (NASDAQ:EXAS) is worth US$11.41 Billion and has recently fallen -2.3% to US$85.57. The latest exchange of 3.57 Million shares is above its average trading activity of 1.77 Million shares. The day began at US$86.01 but the price moved to US$84.48 at one point during the trading and finally capitulating to a session high of US$86.16. The stock tapped a 52-week high of US$97.27 while the mean 12-month price target for the shares is US$103.73.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 15.45, and a price to sales ratio of 25.11. For the past 5 years, the company’s revenue has grown 155.9%, while the company’s earnings per share has grown -15.8%. With an institutional ownership near 89.7%, it carries an earnings per share ratio of -1.43.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 7 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 3 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.58.